ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Pediatric Pulmonology
Volume 13 - 2025 | doi: 10.3389/fped.2025.1653323
Arterialized oxygen tension and unfavorable clinical outcomes in pediatric Cystic Fibrosis
Provisionally accepted- 1Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology, Allergology and Endocrinology, Medical University of Vienna, Vienna, Austria
- 2Institute for Medical Statistics, Centre for Medical Data Science, Medical University of Vienna, Vienna, Austria
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Maintaining good lung function is a primary goal in managing Cystic Fibrosis (CF). As spirometry lacks sensitivity for detecting mild lung disease, early progression often remains unrecognized. To overcome this limitation, more sensitive monitoring tools are needed. We evaluated arterialized oxygen tension (pO2) as an easily accessible, and widely applicable surveillance method. Methods: In this retrospective observational single-center cohort study, arterialized gas exchange was assessed in 103 young people with CF (47 females, 56 males, aged 5-18 years). Trends from baseline (age 5 years) to early adulthood and performance relative to annual best pulmonary function (FEV1) and lung clearance index were examined, along with baseline oxygen tension's predictive value on future FEV1 decline and the occurrence of CF-related complications. Results: pO2 correlated significantly with FEV1 (p<0.001) and inversely with lung clearance index (p<0.001). Higher pO₂ was associated with pancreatic sufficiency (p=0.069) and dual CFTR modulator use (p<0.05), with no differences by sex or chronic Pseudomonas aeruginosa infection. By age 5, 19.8% of young individuals with CF had pO₂ below 80 mmHg (5th percentile), of whom 73.7% had normal FEV1. A linear mixed model showed a steeper FEV1 decline in those with abnormal pO2 at baseline (estimate=0.06 [Z-score*year-1], p<0.001). Early low pO2 was significantly associated with a higher probability of allergic bronchopulmonary aspergillosis (HR=7.69, p=0.016) and a trend towards early CF-related diabetes (HR=2.78, p=0.06) and early chronic Pseudomonas aeruginosa infection (HR=2.38, p=0.09). Conclusions: Early abnormal pO2 at age 5 significantly correlated with accelerated FEV1 decline and a greater probability for CF-related complications. Implementing arterialized oxygen tension may offer valuable insights beyond spirometry alone in identifying high-risk patients.
Keywords: Blood gas monitoring, Respiratory function test, disease progression, secondaryprevention, risk stratification
Received: 24 Jun 2025; Accepted: 19 Sep 2025.
Copyright: © 2025 Gaupmann, Gruber, Schmidthaler, Pauger, Mersi, Graf, Szepfalusi, Renner and Dehlink. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: René Gaupmann, rene.gaupmann@meduniwien.ac.at
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.